Reddy D S, Kulkarni S K
Department of Pharmacology, Panjab University, Chandigarh, India.
Psychopharmacology (Berl). 1996 Dec;128(3):280-92. doi: 10.1007/s002130050136.
Neuroactive steroidal modulation of immobilization-stress and possible involvement of GABA-A and mitochondrial diazepam binding inhibitor (DBI) receptors (MDR) has been investigated in mice. Immobilization of mice for 2 h induced intense antinociception, anxiety state, and associated with a fall in adrenal ascorbic acid levels. Pretreatment with high dose of progesterone (10 mg/kg), a precursor of neurosteroids, significantly decreased the stress-induced antinociception, anxiety and fall in adrenal ascorbic acid, while low doses (1 and 5 mg/kg) or hydrocortisone (10 and 100 mg/kg) were ineffective. In contrast, progesterone (1 mg/kg, for 9 days) produced a significant antistress effect, which was blocked by GABA-A antagonists picrotoxin (1 mg/kg) and bicuculline (1 mg/kg), but not by flumazenil (2 mg/kg), a specific benzodiazepine (BZD) antagonist. 4'-chlordiazepam (0.1 and 0.25 mg/kg), a specific high affinity MDR agonist, produced significant anti-stress effect in a flumazenil-insensitive manner, but was blocked by pretreatment with PK11195 (1.5 mg/kg), a selective partial agonist of MDR, and with bicuculline (1 mg/kg), a potent GABA-A receptor antagonist. At higher doses, progesterone and 4'-chlordiazepam which are effective in immobilization stress also reduced locomotion. However, lower doses of progesterone (6.5 mg/kg) neither affected locomotion, nor produced any motor toxicity on rota-rod test. At the lower doses, the MDR ligand 4'-chlordiazepam (50 micrograms/kg) decreased locomotor activity, without altering motor toxicity on rota-rod test. Further, the per se effects of these treatments on unstressed mice were not significantly different from those of untreated controls, except for plus-maze test. The antistress profile of progesterone may be attributed to the in vivo production of neurosteroid allopregnanolone, thus resembled that of BZDs. Furthermore, the antistress actions are flumazenil-resistant, reaffirming that there may be an increase in the levels of pregnane neurosteroids in vivo, which may act on a specific allosteric site on GABA-A receptors distinct from BZD site. Because 4'-chlordiazepam binds to MDRs and stimulate mitochondrial neurosteroidogenesis, the anti-stress effects of 4'-chlordiazepam may be imputed to its MDR-induced neurosteroids, which then act on GABA-A receptors. These data suggest a pivotal role for GABA-A and mitochondrial DBI receptors in the antistress actions of neurosteroids and reinforces their ameliorative effect in physiological stress.
在小鼠中研究了神经活性甾体对固定应激的调节作用以及GABA - A和线粒体苯二氮䓬结合抑制剂(DBI)受体(MDR)可能的参与情况。将小鼠固定2小时会诱导强烈的抗伤害感受、焦虑状态,并伴有肾上腺抗坏血酸水平下降。用高剂量孕酮(10mg/kg)(一种神经甾体前体)预处理可显著降低应激诱导的抗伤害感受、焦虑以及肾上腺抗坏血酸水平下降,而低剂量(1和5mg/kg)或氢化可的松(10和100mg/kg)则无效。相反,孕酮(1mg/kg,连续9天)产生显著的抗应激作用,该作用被GABA - A拮抗剂印防己毒素(1mg/kg)和荷包牡丹碱(1mg/kg)阻断,但未被特异性苯二氮䓬(BZD)拮抗剂氟马西尼(2mg/kg)阻断。4'-氯地西泮(0.1和0.25mg/kg),一种特异性高亲和力MDR激动剂,以氟马西尼不敏感的方式产生显著的抗应激作用,但被MDR的选择性部分激动剂PK11195(1.5mg/kg)和强效GABA - A受体拮抗剂荷包牡丹碱(1mg/kg)预处理所阻断。在较高剂量时,对固定应激有效的孕酮和4'-氯地西泮也会降低运动能力。然而,较低剂量的孕酮(6.5mg/kg)既不影响运动能力,也未在转棒试验中产生任何运动毒性。在较低剂量时,MDR配体4'-氯地西泮(50μg/kg)降低运动活性,但不改变转棒试验中的运动毒性。此外,除了高架十字迷宫试验外,这些处理对未受应激小鼠的自身影响与未处理的对照组无显著差异。孕酮的抗应激特征可能归因于体内神经甾体别孕烷醇酮的产生,因此类似于苯二氮䓬类药物。此外,抗应激作用对氟马西尼耐药,再次证实体内孕烷神经甾体水平可能升高,其可能作用于GABA - A受体上与BZD位点不同的特定变构位点。由于4'-氯地西泮与MDR结合并刺激线粒体神经甾体生成,4'-氯地西泮的抗应激作用可能归因于其MDR诱导的神经甾体,然后这些神经甾体作用于GABA - A受体。这些数据表明GABA - A和线粒体DBI受体在神经甾体的抗应激作用中起关键作用,并强化了它们在生理应激中的改善作用。